Korean Stroke Cohort for functioning and rehabilitation (KOSCO): study rationale and protocol of a multi-centre prospective cohort study
verfasst von:
Won Hyuk Chang, Min Kyun Sohn, Jongmin Lee, Deog Young Kim, Sam-Gyu Lee, Yong-Il Shin, Gyung-Jae Oh, Yang-Soo Lee, Min Cheol Joo, Eun Young Han, Yun-Hee Kim
Development of a long-term stroke care plan requires serial assessment of long-term patient function and consideration of caregiver mood. However, to date, few comprehensive cohort studies have included both stroke patients and caregivers.
Methods/Design
KOSCO is a large, multi-centre prospective cohort study for all acute first-ever stroke patients admitted to participating hospitals in nine distinct areas of Korea. This study is designed as a 10-year, longitudinal follow-up investigating the residual disabilities, activity limitations, and quality of life issues arising in patients suffering from first-ever stroke. The main objectives of this study are to identify the factors that influence residual disability and long-term quality of life. The secondary objectives of this study are to determine the risk of mortality and recurrent vascular events in patients with acute first-ever stroke. We will investigate longitudinal health behaviors and patterns of healthcare utilization, including stroke rehabilitation care. We will also investigate the long-term health status, mood, and quality of life in stroke patient caregivers. In addition, we will identify baseline and ongoing characteristics that are associated with our secondary outcomes.
Discussion
KOSCO is a prospective, multi-centre, 10-year longitudinal follow-up study investigating the residual disabilities, activity limitations, and quality of life issues arising in patients suffering from first-ever stroke.
Hinweise
Competing interest
The authors declare that they have no competing interest.
Authors’ contributions
WHC: contribution to conception and design; acquisition of data; involvement in drafting the manuscript; final approval of the version to be published. MKS, JL, DYK, SGL, YIS, GJO: contribution to conception and design; acquisition of data; final approval of the version to be published. YSL, MCJ, EYH: acquisition of data; final approval of the version to be published. YHK: contribution to conception and design; acquisition of data; revising the manuscript critically; final approval of the version to be published.
Abkürzungen
KOSCO
Korean Stroke Cohort for Functioning and Rehabilitation
K-NIHSS
Korean version of the National Institute of Health Stroke Scale
mRS
Modified Rankin scale
K-MMSE
Korean Mini-Mental State Examination
FMA
Fugl-Meyer assessment
FAC
Functional ambulatory category
ASHA-NOMS
American Speech-Language-Hearing Association National Outcome Measurement System Swallowing Scale
K-FAST
Korean Version of the Frenchay Aphasia Screening Test
GDS-SF
Geriatric depression scale-short form
EQ
Euro quality of life
PWI-SF
Psychosocial Well-being index-short form
RNLI
Reintegration to Normal Living Index
Background
Although stroke is a world-wide problem [1,2], the burden of stroke is particularly heavy in Korea as the third most common cause of death after heart disease and cancer [3]. Stroke is a medical emergency associated with a very high risk of death in the acute and subacute phases and with a continuous excess risk of death [4]. The greatest predictors of long-term survival after stroke include age, pre-stroke functional level, and functional status at six months after stroke [5,6]. Therefore, it is recommended that stroke patients reduce dependency by six months in order to improve chances of long term survival [5]. While mortality and case fatality rates from stroke have been declining due to risk factor control and improvement in treatment and secondary prevention, the incidence of stroke has increased gradually, in part due to a rapidly aging population [7-9]. Many survivors are left with sequelae to some degree, and disability after stroke remains an important burden to patients, caregivers, and society [10]. It is likely that the burden of post-stroke disability will become an even greater public health problem, considering the expected increase in stroke prevalence [11]. Therefore, studies measuring the burden of stroke will need to include post-stroke disability in addition to mortality.
Many cohort studies of stroke patients have demonstrated the long-term neuropsychological deficits and functional outcomes in United States, Europe, and Asia [10-13]. However, most previous cohort studies have only investigated functional outcomes of stroke during the chronic stage of the disease [10,13]. Stroke recovery is a complex process that probably occurs through a combination of spontaneous and learning-dependent processes, including restitution, substitution, and compensation [14]. This recovery is a dynamic process that cannot be encapsulated at any single timepoint. Also, stroke is a heterogeneous disease by nature. Therefore, long-term prospective studies with long-term assessments in large stroke patient populations are needed in order to rigorously investigate the functional outcomes of this disease.
Anzeige
Stroke survivors usually suffer from impairment in many different domains, including motor, mobility, speech and language, swallowing, vision, sensation, and cognition [11,15]. Although there seems to be a moderate non-linear relation between impairment and function [11,14], the relationship between several different impairments and their combined contribution to function impairment remains poorly understood. Several cohort studies have previously assessed the relationship between these impairment domains and function in stroke patients, albeit without investigating the interaction between functional domains [10-13]. In addition, most studies have not investigated patients in person but rather have relied on telephone interviews. Although a structured telephone interview is widely favored and recommended by researchers [16], it is suboptimal for measuring stroke outcomes. Indeed, it is hard to collect functional data by telephone from stroke patients with moderate to severe levels of language or cognitive impairment [17].
The burden of stroke can extend beyond the stroke patient, and there is a need to better understand its impact on caregivers. Caregivers of stroke survivors tend to have elevated levels of depression during both acute and chronic phases of care [18,19]. Understanding stroke-related patient problems reported by caregivers is important because they are risk factors for caregiver depression, which can be a subsequent risk factor for negative outcomes of the patient [19]. Although caregiver mood may change over time due to learned coping mechanisms, few studies have actually addressed long-term changes in mood and quality of life in caregivers.
Development of a long-term stroke care plan first requires serial assessment of long-term patient function alongside consideration of caregiver mood. We will therefore perform the Korean Stroke Cohort for Functioning and Rehabilitation (KOSCO): a large, multi-centre prospective cohort study on comprehensive assessments of survival rate, recurrence rate, function, mood and quality of life of patients with an ischemic or hemorrhagic stroke, and of their caregivers, by face-to-face interview.
Methods
Study design
KOSCO is a large, multi-centre, prospective cohort study for all acute first-ever stroke patients admitted to the participating hospitals in nine distinct areas of Korea. This 10-year longitudinal follow-up study of stroke patients is a prospective multi-centre project that investigates the residual disabilities, activity limitation, and quality of life of patients suffering from first-ever stroke. The study further identifies the factors that influence patient residual disability and long-term quality of life. Written informed consent is obtained from all patients prior to inclusion in the study, and the study protocol is approved by the ethics committees of each hospital.
Anzeige
Objectives
The main objective of this study is to identify the factors that influence long-term residual disabilities, activity limitations, and quality of life in acute first-ever stroke patients. The secondary objectives are to determine the risks of mortality and recurrent vascular events in patients with acute first-ever stroke. We will investigate long-term health behaviors and healthcare utilization patterns, including stroke rehabilitation care. We will also investigate the changes in health, mood, and quality of life of patient caregivers over time. In addition, we will identify the baseline and follow up characteristics that are associated with our secondary outcomes.
Study population
All consecutive patients with an acute first-ever stroke, admitted to the representative hospitals in the nine distinct areas of Korea, will be asked to participate in the study. Participating study centres are Samsung Medical Center, Seoul; Severance Hospital, Seoul; Konkuk University Hospital, Seoul; Chungnam National University Hospital, Daejeon; Chonnam National University Hospital, Gwangu; Pusan National University Yangsan Hospital, Yangsan; Kyungpook National University Hospital, Deagu; Wonkwang University Hospital, Iksan; and Jeju National University Hospital, Jeju.
The followings are criteria for inclusion in the study:
1.
First-ever acute stroke (ischemic stroke or intracerebral hemorrhage) with corresponding lesion and/or evidence of acute arterial occlusion on CT (A)- or MRI/A-scan.
2.
Age ≥ 19 years at onset of stroke.
3.
Onset of symptoms within seven days prior to inclusion.
Acute stroke is defined as a rapidly evolving, focal neurological deficit persisting for more than 24 hours. On the basis of neuroimaging, stroke is further classified as ischemic or hemorrhagic stroke. Hemorrhagic transformation of an ischemic stroke will be classified as an ischemic stroke.
The followings are criteria for exclusion in the study:
1.
Transient ischemic attack.
2.
History of stroke.
3.
Traumatic intracerebral hemorrhage.
4.
Not Korean.
Transient ischemic attack is defined as a rapidly evolving, focal neurological deficit with only vascular etiology lasting less than 24 hours.
Procedures
All eligible patients will be recruited at the time of stroke evaluation. Patient recruitment is planned over a three to four year period, and we intend to include 7,500 patients in the cohort. After providing written informed consent, patients will formally enter the study. If the patient is unable to provide informed consent, consent will be obtained from the patient’s legally authorized representative.
After baseline assessment, patients will be assessed during face-to-face interviews at 7 days, discharge, 3 months, 6 months, 12 months, 18 months and 24 months after stroke onset and every year thereafter for the duration of the study period. Figure 1 depicts a flowchart of the study design.
Figure 1
Flowchart of the KOSCO study.
×
Anzeige
Baseline review of medical records
At baseline, a complete enumeration survey of all patients will be performed using a review of medical records at first admission. Survey items include demographic data such as age, sex, education, marital status, and employment. Presence of cerebrovascular risk factors will be assessed by standardized, structured questionnaires and will be classified according to the current guidelines of the American Heart Association [20]. Comorbidity will be assessed using the Charlson comorbidity index [21]. Initial stroke severity will be recorded at the time of hospital arrival using the National Institute of Health Stroke Scale (NIHSS) [22] and Glasgow Coma Scale [23] for ischemic and hemorrhagic strokes, respectively. Functional performance prior to the index event will be assessed by modified Rankin scale (mRS) [24].
Clinical signs, symptoms, and duration of stroke will be recorded using review of medical records. Physical examination findings and laboratory measures will also be recorded. Furthermore, the course of the disease during admission will be reported, including information on medication use, (intra-venous or arterial) thrombolysis, or other treatments and complications. Development of recurrent cerebrovascular event or neurologic aggravation will also be reported. In addition, details of the first admission course of all patients, including consultation to rehabilitation department, inpatient rehabilitation treatment, transfer to rehabilitation department, discharge destination, and discharge status, will be recorded. Table 1 shows an overview of all planned investigations from medical record review.
Table 1
Baseline medical record assessments of stroke patients
Assessment
Demographics
Age
Sex
Dominant hand
Marital status
Years of education
Medical history
Cerebrovascular risk factors
Pre-stroke functional level
Comorbidities
Stroke characteristics
Etiology
Territory
Symptom duration
Initial National Institute of Health Stroke Scale in ischemic stroke
Classification of stroke: etiology and neuro-imaging
Etiology of ischemic stroke will be classified according to the TOAST criteria [25]. Etiology of intracerebral hemorrhage will be classified according to previous stroke classification [25]. Etiology will be based on neuro-imaging, medical history, and use of medication. All patients will undergo neuroimaging, and CT-angiography, MR-angiography, or ultrasound will be performed according to standard clinical practice. CT- and MRI-scans will be reviewed by neuroimaging specialists in each institute. Ischemic strokes will be classified according to arterial territory and as lacunar or territorial. Intracerebral hemorrhage will be classified as infratentorial (brainstem or cerebellar) or supratentorial hemorrhage (lobar, deep or ventricular), with or without ventricular involvement. Lobar hemorrhage will be further subclassified as frontal, temporal, parietal, or occipital.
Follow-up
All patients will be approached for follow-up assessment using a two-step approach. First, all patients will be contacted by telephone. In cases of an invalid phone number, a second telephone call will be made to contact caregivers of patients. Information on patient vital status will be obtained in this way through telephone interview of patient or caregivers. Subsequently, all living patients will be invited to visit our research centre for functional assessment batteries, structured self-administered questionnaires, and face-to-face interviews (Table 2). If patients are not able to visit our research centre, these same investigations will be performed at their homes. Main caregivers will also visit our research centre or be visited by our researchers for structured self-administered questionnaires and face-to-face interviews (Table 3).
Table 2
Neuropsychological assessments and structured questionnaires for stroke patients of the KOSCO study
Domain
Assessment
Stroke severity
National Institute of Health Stroke Scale
Activities of daily living
Korean modified Barthel Index
Functional Independence Measure
Cognition function
Korean Mini-Mental State Examination
Motor function
Fugl-Meyer Assessment
modified Ashworth scale
9-hole peg board test
Mobility function
Functional Ambulatory Category
Swallowing function
American Speech-Language-Hearing Association National Outcome Measurement System Swallowing Scale
Language function
Korean Version of Frenchay Aphasia Screening Test
Disability
modified Rankin scale
Mood
Geriatric depression scale-short form
Quality of life
Euro Quality of Life-5D
Subjective health condition
Psychosocial Well-being index-short form
Reintegration to Normal Living Index
Demographics
Occupation
Marital status
Living conditions
Lifestyle habits
Alcohol consumption
Smoking
Exercise
Health care utilization
General medical services
Rehabilitation services
Table 3
Structured questionnaires for main caregivers of the KOSCO study
Assessment
Demographics
Age
Sex
Dominant hand
Marital status
Year of education
Living conditions
Occupation
Knowledge of stroke
Knowledge of stroke questionnaires
Mood
Geriatric depression scale-short form
Quality of life
Euro Quality of Life-5D
Subjective health condition
Psychosocial Well-being index-short form
Subjective caregiving burden
Subjective caregiving burden questionnaires
Patient follow-up has begun in 2012 and is planned to finish by the end of 2021.
Functional assessment battery
Baseline
Seven days after onset of stroke, baseline evaluation will be performed using face-to-face functional assessment, including K-NIHSS for stroke severity, Korean Mini-Mental State Examination (K-MMSE) [26] for cognitive function, Fugl-Meyer Assessment (FMA) [27] for motor function, Functional Ambulatory Category (FAC) [28] for mobility and gait, the American Speech-Language-Hearing Association National Outcome Measurement System Swallowing Scale (ASHA-NOMS) [29] for swallowing function, the Korean Version of the Frenchay Aphasia Screening Test (K-FAST) [30] for language function, and mRS for general functional level.
During first admission
At discharge, all patients will be evaluated using a face-to-face functional assessment battery that includes the Functional Independence Measure [31], Korean modified Barthel Index [32], K-NIHSS, K-MMSE, FMA, FAC, ASHA-NOMS, K-FAST, and mRS.
For patients to be transferred to the rehabilitation department, this same discharge evaluation will also be performed on the day of their transfer.
Follow-up
At every follow-up visit, all patients will undergo the same evaluation that was performed at discharge using face-to-face functional assessment battery.
Structured self-administered questionnaires for patients
At discharge, all patients will complete structured self-administered questionnaires and undergo a face-to-face interview for mood and quality of life evaluation with the Geriatric depression scale-short form (GDS-SF) [33] and Euro Quality of Life (EQ)-5D [34].
For patients to be transferred to the rehabilitation department, same discharge questionnaires and interview will also be performed on the day of their transfer.
At every follow-up visit, all patients will complete structured self-administered questionnaires and undergo a face-to-face interview. Standardized questionnaires on patient demographics, marital status, occupation, living conditions, stroke recurrence, and lifestyle habits (i.e., alcohol consumption, smoking, exercise) will be administered. Alcohol consumption will be defined as units per day, and the frequency of alcohol consumption will be noted. Cigarette smoking behavior will be defined as never, former, or current. Subsequently, former and current smoking behavior will be quantified as the number of pack-years, calculated as the number of packs of cigarettes smoked per day multiplied by the number of years a participant has smoked. Exercise will be expressed in amount and frequency of physical activity per week. Health care utilization information will also be collected via standardized questionnaires. Patients will report if they have had an inpatient rehabilitation facility stay, a skilled nursing facility stay, used home health services, used outpatient rehabilitation services, the number of physician office visits, and/or were readmitted to a hospital after discharge from the initial stroke-induced hospitalization. For those patients that have difficulty in completing the survey, the main caregiver will complete it in their stead. In addition, at each follow-up visit, patients will complete structured self-administered questionnaires and undergo face-to-face interviews to assess for mood, quality of life, and subjective health conditions including GDS-SF, EQ-5D, Psychosocial Well-being index-short form (PWI-SF) [35] and Reintegration to Normal Living Index (RNLI) [36] assessments.
Structured self-administered questionnaires for main caregivers
At every follow-up, all caregivers will complete structured self-administered questionnaires and undergo a face-to-face interview. Standardized questionnaires on demographics, marital status, occupation, living conditions, and life style habits will be administered. Also, standardized questionnaires will include questions on the subjective caregiving burden and knowledge of stroke. In addition, all caregivers will complete structured self-administered questionnaires and undergo a face-to-face interview for mood, quality of life, subjective health condition including GDS-SF, EQ-5D, and PWI-SF.
Anzeige
Statistical analysis
Multivariate analysis by linear or logistic regression will be performed to identify independent predictors of the primary outcome. A repeated measures ANOVA will be used to investigate change in continuous variables over time points. In case of skewed distributions which cannot be normalized, corresponding nonparametric tests will be used. Cumulative risk of mortality and recurrent vascular events will be estimated with Kaplan-Meier analysis. Cox proportional hazard models will be used to calculate the mortality and recurrent vascular events in the follow-up period, with adjustments for the necessary covariates. The relative risk (hazards ratios) will be calculated with their corresponding 95% confidence intervals.
Discussion
KOSCO is a prospective, multi-centre, ten-year follow-up study of the residual disabilities, activity limitations, and quality of life of first-ever stroke patients. In KOSCO study, 7,500 first-ever stroke patients will be consecutively recruited from the participating hospitals in the nine distinct areas of Korea over three years. The main goal of this cohort study is to identify the factors that influence patient residual disability and long-term quality of life. In addition, we intend to determine the factors that influence the long-term mood, and quality of life in stroke patient caregivers.
This study has much strength, including its multi-centre prospective design with long-term multiple follow-up assessments. The multi-centre design allows for a large sample size, and therefore greater statistical power, drawing from a population that covers much of Korea. The prospective design allows us to obtain an accurate evaluation of the residual disabilities, activity limitations, and quality of life of first-ever stroke patients. Another advantage of our study is that it will include patients with hemorrhagic and ischemic stroke. These inclusion criteria allow us to study the entire spectrum of stroke. Additionally, since patients will be eligible for inclusion in this study only if they have positive brain imaging corresponding with neurological deficits, the KOSCO study will have a clearly diagnosed population without potential for misclassification of patients.
Most importantly, the KOSCO study has three key strengths that distinguish it from previous large multi-centre cohort studies. First, unlike previous cohort studies, patient evaluation in this study will be performed by the face-to-face assessment rather than telephone interview. This approach will allow us to more accurately evaluate patients. Second, surveys will be given to both caregivers and patients. This will allow us to gain insight on the greater burden of stroke. Finally, lifestyle and healthcare utilization information, including on stroke rehabilitation, will also be collected prospectively. This can provide insight on the optimal time points for interventions and could ultimately lead to improved guidelines for chronic stroke patients.
Anzeige
Completion of this study will contribute to better understanding of the residual disabilities, activity limitations, and quality of life issues that arise in acute first-ever stroke patients. It may also provide physicians with better information on how to better treat stroke patients. Given the growing burden of stroke, identification of the factors that influence residual disability and long-term quality of life will be necessary for improving healthcare outcomes for stroke patients. In addition, it may contribute to better understanding of the mood, and quality of life of patient caregivers. Finally, the results of this cohort study can be used to inform healthcare policy decisions that could reduce the burden of post-stroke morbidity.
Acknowledgements
This work was supported by the Research Program funded by the Korea Center for Disease Control and Prevention (2013E3301702).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The authors declare that they have no competing interest.
Authors’ contributions
WHC: contribution to conception and design; acquisition of data; involvement in drafting the manuscript; final approval of the version to be published. MKS, JL, DYK, SGL, YIS, GJO: contribution to conception and design; acquisition of data; final approval of the version to be published. YSL, MCJ, EYH: acquisition of data; final approval of the version to be published. YHK: contribution to conception and design; acquisition of data; revising the manuscript critically; final approval of the version to be published.
Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.
Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.
Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.
Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.
